US$ 28.58
should bpc 157 be taken daily BPC-157 Dosing (Common Protocols), ๐น Oral / Subcutaneous, โข 500 mcg daily, โข Duration: 6 weeks, ๐น Intramuscular / Peritendinous, โข 1 mg daily, โข Duration: 6 weeks, โ ๏ธ Note:, Not approved by FDA or BPC-157: What you need to
Description
Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
However, the critical limitation remains the near-total absence of rigorous human clinical trial data

This balanced approach can harness the benefits while minimizing uncertainties
BPC-157 has a favorable safety profile, with no significant toxicity reported in clinical or preclinical studies
